Kyverna Therapeutics Files $300M Mixed Shelf Kyverna filed a $300M Form S‑3 mixed securities shelf on Mar 27, 2026, enabling multi‑year issuance of equity or debt and preserving optionality for financing or deals.

Kyverna Therapeutics Files $300M Mixed Shelf: Kyverna filed a $300M Form S‑3 mixed securities shelf on Mar 27, 2026, enabling multi‑year issuance of equity or debt and preserving optionality for financing or… 👈 Read full analysis #KyvernaTherapeutics #MixedShelf #Securities #Equity #DebtIssuance